Spatial Habitat Features Derived from Multiparametric Magnetic Resonance Imaging Data Are Associated with Molecular Subtype and 12-Month Survival Status in Glioblastoma Multiforme

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2015 Sep 15

PMID 26368923

Citations 15

Authors

Joonsang Lee

Shivali Narang

Juan Martinez

Ganesh Rao

Arvind Rao

Affiliations

Soon will be listed here.

Abstract

One of the most common and aggressive malignant brain tumors is Glioblastoma multiforme. Despite the multimodality treatment such as radiation therapy and chemotherapy (temozolomide: TMZ), the median survival rate of glioblastoma patient is less than 15 months. In this study, we investigated the association between measures of spatial diversity derived from spatial point pattern analysis of multiparametric magnetic resonance imaging (MRI) data with molecular status as well as 12-month survival in glioblastoma. We obtained 27 measures of spatial proximity (diversity) via spatial point pattern analysis of multiparametric T1 post-contrast and T2 fluid-attenuated inversion recovery MRI data. These measures were used to predict 12-month survival status (≤12 or >12 months) in 74 glioblastoma patients. Kaplan-Meier with receiver operating characteristic analyses was used to assess the relationship between derived spatial features and 12-month survival status as well as molecular subtype status in patients with glioblastoma. Kaplan-Meier survival analysis revealed that 14 spatial features were capable of stratifying overall survival in a statistically significant manner. For prediction of 12-month survival status based on these diversity indices, sensitivity and specificity were 0.86 and 0.64, respectively. The area under the receiver operating characteristic curve and the accuracy were 0.76 and 0.75, respectively. For prediction of molecular subtype status, proneural subtype shows highest accuracy of 0.93 among all molecular subtypes based on receiver operating characteristic analysis. We find that measures of spatial diversity from point pattern analysis of intensity habitats from T1 post-contrast and T2 fluid-attenuated inversion recovery images are associated with both tumor subtype status and 12-month survival status and may therefore be useful indicators of patient prognosis, in addition to providing potential guidance for molecularly-targeted therapies in Glioblastoma multiforme.

Citing Articles

Preoperative vascular heterogeneity based on dynamic susceptibility contrast MRI in predicting spatial pattern of locally recurrent high-grade gliomas.

Wang H, Zeng L, Wu H, Tian J, Xie H, Zhang L Eur Radiol. 2023; 34(3):1982-1993.

PMID: 37658897 PMC: 10873240. DOI: 10.1007/s00330-023-10149-6.

Visualising spatial heterogeneity in glioblastoma using imaging habitats.

Waqar M, van Houdt P, Hessen E, Li K, Zhu X, Jackson A Front Oncol. 2022; 12:1037896.

PMID: 36505856 PMC: 9731157. DOI: 10.3389/fonc.2022.1037896.

Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study.

Bailo M, Pecco N, Callea M, Scifo P, Gagliardi F, Presotto L Front Neurosci. 2022; 16:885291.

PMID: 35911979 PMC: 9326318. DOI: 10.3389/fnins.2022.885291.

Magnetic resonance biomarkers in radiation oncology: The report of AAPM Task Group 294.

McGee K, Hwang K, Sullivan D, Kurhanewicz J, Hu Y, Wang J Med Phys. 2021; 48(7):e697-e732.

PMID: 33864283 PMC: 8361924. DOI: 10.1002/mp.14884.

A Bayesian 2D functional linear model for gray-level co-occurrence matrices in texture analysis of lower grade gliomas.

Chekouo T, Mohammed S, Rao A Neuroimage Clin. 2020; 28:102437.

PMID: 33035963 PMC: 7554657. DOI: 10.1016/j.nicl.2020.102437.

References

Cheng N, Fang Y, Chang J, Huang C, Tsan D, Ng S . Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma. J Nucl Med. 2013; 54(10):1703-9. DOI: 10.2967/jnumed.112.119289. View

Schmidt M, Lipson H . Distilling free-form natural laws from experimental data. Science. 2009; 324(5923):81-5. DOI: 10.1126/science.1165893. View

Sled J, Zijdenbos A, Evans A . A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging. 1998; 17(1):87-97. DOI: 10.1109/42.668698. View

Gatenby R, Grove O, Gillies R . Quantitative imaging in cancer evolution and ecology. Radiology. 2013; 269(1):8-15. PMC: 3781355. DOI: 10.1148/radiol.13122697. View

Aerts H, Velazquez E, Leijenaar R, Parmar C, Grossmann P, Carvalho S . Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014; 5:4006. PMC: 4059926. DOI: 10.1038/ncomms5006. View

Mazurowski M, Desjardins A, Malof J . Imaging descriptors improve the predictive power of survival models for glioblastoma patients. Neuro Oncol. 2013; 15(10):1389-94. PMC: 3779027. DOI: 10.1093/neuonc/nos335. View

Affronti M, Heery C, Herndon 2nd J, Rich J, Reardon D, Desjardins A . Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy. Cancer. 2009; 115(15):3501-11. DOI: 10.1002/cncr.24398. View

Jiao Y, Berman H, Kiehl T, Torquato S . Spatial organization and correlations of cell nuclei in brain tumors. PLoS One. 2011; 6(11):e27323. PMC: 3217938. DOI: 10.1371/journal.pone.0027323. View

Zhou M, Hall L, Goldgof D, Russo R, Balagurunathan Y, Gillies R . Radiologically defined ecological dynamics and clinical outcomes in glioblastoma multiforme: preliminary results. Transl Oncol. 2014; 7(1):5-13. PMC: 3998688. DOI: 10.1593/tlo.13730. View

10.

Grove O, Berglund A, Schabath M, Aerts H, Dekker A, Wang H . Quantitative computed tomographic descriptors associate tumor shape complexity and intratumor heterogeneity with prognosis in lung adenocarcinoma. PLoS One. 2015; 10(3):e0118261. PMC: 4349806. DOI: 10.1371/journal.pone.0118261. View

11.

Bedard P, Hansen A, Ratain M, Siu L . Tumour heterogeneity in the clinic. Nature. 2013; 501(7467):355-64. PMC: 5224525. DOI: 10.1038/nature12627. View

12.

Miles K, Ganeshan B, Griffiths M, Young R, Chatwin C . Colorectal cancer: texture analysis of portal phase hepatic CT images as a potential marker of survival. Radiology. 2009; 250(2):444-52. DOI: 10.1148/radiol.2502071879. View

13.

Johnson D, Patrick ONeill B . Glioblastoma survival in the United States before and during the temozolomide era. J Neurooncol. 2011; 107(2):359-64. DOI: 10.1007/s11060-011-0749-4. View

14.

Inda M, Bonavia R, Mukasa A, Narita Y, Sah D, Vandenberg S . Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. Genes Dev. 2010; 24(16):1731-45. PMC: 2922502. DOI: 10.1101/gad.1890510. View

15.

Verhaak R, Hoadley K, Purdom E, Wang V, Qi Y, Wilkerson M . Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010; 17(1):98-110. PMC: 2818769. DOI: 10.1016/j.ccr.2009.12.020. View

16.

Held K, Kops E, Krause B, Wells 3rd W, Kikinis R . Markov random field segmentation of brain MR images. IEEE Trans Med Imaging. 1998; 16(6):878-86. DOI: 10.1109/42.650883. View

17.

Gonzalez-Garcia I, Sole R, Costa J . Metapopulation dynamics and spatial heterogeneity in cancer. Proc Natl Acad Sci U S A. 2002; 99(20):13085-9. PMC: 130590. DOI: 10.1073/pnas.202139299. View

18.

Chen C, Daponte J, Fox M . Fractal feature analysis and classification in medical imaging. IEEE Trans Med Imaging. 1989; 8(2):133-42. DOI: 10.1109/42.24861. View